Whitebox Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6,956,279
| Closed | -$5.98M | – | 101 |
|
|
2019
Q4 | $5.98M | Hold |
6,956,279
| – | – | 0.2% | 39 |
|
|
2019
Q3 | $3.96M | Hold |
6,956,279
| – | – | 0.14% | 59 |
|
|
2019
Q2 | $3.62M | Hold |
6,956,279
| – | – | 0.13% | 66 |
|
|
2019
Q1 | $3.13M | Hold |
6,956,279
| – | – | 0.1% | 55 |
|
|
2018
Q4 | $3.34M | Hold |
6,956,279
| – | – | 0.15% | 58 |
|
|
2018
Q3 | $3.9M | Hold |
6,956,279
| – | – | 0.12% | 60 |
|
|
2018
Q2 | $3.48M | Hold |
6,956,279
| – | – | 0.11% | 61 |
|
|
2018
Q1 | $2.94M | Hold |
6,956,279
| – | – | 0.09% | 66 |
|
|
2017
Q4 | $2.64M | Sell |
6,956,279
-225,428
| -3% | -$85.5K | 0.07% | 64 |
|
|
2017
Q3 | $2.58M | Hold |
7,181,707
| – | – | 0.08% | 69 |
|
|
2017
Q2 | $2.73M | Hold |
7,181,707
| – | – | 0.11% | 74 |
|
|
2017
Q1 | $3.23M | Sell |
7,181,707
-4,008,200
| -36% | -$1.76M | 0.12% | 57 |
|
|
2016
Q4 | $4.25M | Sell |
11,189,907
-4,970,542
| -31% | -$1.68M | 0.17% | 60 |
|
|
2016
Q3 | $4.32M | Hold |
16,160,449
| – | – | 0.18% | 58 |
|
|
2016
Q2 | $3.88M | Hold |
16,160,449
| – | – | 0.1% | 64 |
|
|
2016
Q1 | $1.84M | Hold |
16,160,449
| – | – | 0.05% | 77 |
|
|
2015
Q4 | $1.82M | Sell |
16,160,449
-5,057,729
| -24% | -$714K | 0.05% | 130 |
|
|
2015
Q3 | $4.04M | Buy |
21,218,178
+1,073,921
| +5% | +$365K | 0.18% | 115 |
|
|
2015
Q2 | $14.1M | Buy |
20,144,257
+10,000
| +0% | +$6.92K | 0.61% | 35 |
|
|
2015
Q1 | $13.7M | Sell |
20,134,257
-8,458,526
| -30% | -$5.92M | 0.53% | 36 |
|
|
2014
Q4 | $22.6M | Sell |
28,592,783
-366,069
| -1% | -$250K | 0.9% | 24 |
|
|
2014
Q3 | $13.5M | Buy |
28,958,852
+5,218,360
| +22% | +$2.53M | 0.52% | 45 |
|
|
2014
Q2 | $11.9M | Buy |
23,740,492
+7,144,724
| +43% | +$3.46M | 0.47% | 56 |
|
|
2014
Q1 | $5.14M | Sell |
16,595,768
-968,359
| -6% | -$360K | 0.22% | 88 |
|
|
2013
Q4 | $5.97M | Buy |
17,564,127
+915,597
| +5% | +$1.11M | 0.26% | 60 |
|
|
2013
Q3 | $33.6M | Buy |
16,648,530
+1,182,537
| +8% | +$2.25M | 1.77% | 11 |
|
|
2013
Q2 | $29.8M | Buy |
+15,465,993
| New | +$27.2M | 1.57% | 14 |
|
Whitebox Advisors's GCVRZ Position: Q1 2020 in Review
Whitebox Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 6,956,279 shares — an estimated $5.98M sold.
Whitebox Advisors first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $33.6M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Whitebox Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Whitebox Advisors sold 6,956,279 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $5.98M.
- Whitebox Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Whitebox Advisors's Sanofi Contingent Value Rights position peaked at $33.6M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Whitebox Advisors's 13F filing for Q1 2020, filed 15 May 2020.